Metagenomi, Inc. Common Stock
Metagenomi, Inc. Common Stock (MGX) Stock Overview
Explore Metagenomi, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
66.1M
P/E Ratio
-0.75
EPS (TTM)
$-2.39
ROE
-0.47%
MGX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Metagenomi, Inc. Common Stock (MGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 60.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.07.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.75 and a market capitalization of 66.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.